glp-1 tirzepatide side effects Systemic of dually activating and GIP GLP-1 drugs such as semaglutide

RETA reduced blood glucose from ~ 190 mg/dL to approximately 80 mg/dL after 1 week, which steadily rose after 2 weeks of treatment over the remainder of the study to ~130 mg/dL while Veh controls maintained blood glucose ~ 180 mg/dL from baseline to endpoint (Fig

If 5 days has passed since your dosing date, we recommend skipping the current week and resume the medication on your next regular dosing day the following week

It often comes hand in hand with diabetes, high blood pressure, and cholesterol problems

Common side effects may include nausea, vomiting, diarrhea, abdominal pain, constipation, headache, dizziness, fatigue, or mild injection site reactions

Decreased Appetite: Some individuals may experience a decrease in appetite while taking GLP-1 medications, which can be both a desired effect (supporting weight loss) and a potential side effect (leading to inadequate calorie intake)

[6] Eli Lilly